Terms: = Brain cancer AND STK11, LKB1, 6794, ENSG00000118046, Q15831, PJS AND Prognosis
5 results:
1. [Cytopathological characteristics of SMARCA4-deficient thoracic undifferentiated tumors in serous effusion].
Wang WN; Liu XT; Liang YM
Zhonghua Bing Li Xue Za Zhi; 2024 Feb; 53(2):143-148. PubMed ID: 38281781
[No Abstract] [Full Text] [Related]
2. Widely metastatic atypical pituitary adenoma with mTOR pathway stk11(F298L) mutation treated with everolimus therapy.
Donovan LE; Arnal AV; Wang SH; Odia Y
CNS Oncol; 2016 Oct; 5(4):203-9. PubMed ID: 27615706
[TBL] [Abstract] [Full Text] [Related]
3. Metformin: a modulator of bevacizumab activity in cancer? A case report.
Indraccolo S; Randon G; Zulato E; Nardin M; Aliberti C; Pomerri F; Casarin A; Nicoletto MO
Cancer Biol Ther; 2015; 16(2):210-4. PubMed ID: 25607951
[TBL] [Abstract] [Full Text] [Related]
4. Methylation profiles of thirty four promoter-CpG islands and concordant methylation behaviours of sixteen genes that may contribute to carcinogenesis of astrocytoma.
Yu J; Zhang H; Gu J; Lin S; Li J; Lu W; Wang Y; Zhu J
BMC Cancer; 2004 Sep; 4():65. PubMed ID: 15367334
[TBL] [Abstract] [Full Text] [Related]
5. Clinical genetics of multiple endocrine neoplasias, Carney complex and related syndromes.
Stratakis CA
J Endocrinol Invest; 2001 May; 24(5):370-83. PubMed ID: 11407658
[TBL] [Abstract] [Full Text] [Related]
